Opko Health, Inc. SEC filings OPK
Opko Health, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Sep 14, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 15, 2023 | — |
| 424B5 | Prospectus supplement | Oct 25, 2019 | — |
| 424B5 | Prospectus supplement | Oct 24, 2019 | — |
| 424B5 | Prospectus supplement | Oct 22, 2019 | — |
| 424B2 | Prospectus | Feb 6, 2019 | — |
| 424B7 | Filing | Feb 5, 2019 | — |
| FWP | Free writing prospectus | Feb 5, 2019 | — |
| 424B5 | Prospectus supplement | Feb 4, 2019 | — |
| S-3ASR | Automatic shelf registration | Jan 29, 2019 | — |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OPK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC filer status
- Accelerated filer
- SEC CIK
- 944809
- Former names
- EXEGENICS INC (until Jun 13, 2007); eXegenics Inc (until Jun 13, 2007); CYTOCLONAL PHARMACEUTICS INC /DE (until Jun 4, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.